John Farah, PhD, joined Veradigm in 2018 as a Clinical Science Liaison. Working collaboratively with internal stakeholders, John generates content that identifies challenges relevant to the biopharmaceutical and payer communities and proposes solutions by leveraging Veradigm clinical data sources and technologies. John cultivates relationships with thought leaders in medical and scientific communities, offering opportunities for collaborations in support of the Veradigm mission to insightfully transform health.
John earned his doctorate in physiology from the Uniformed Services University of the Health Sciences in Bethesda, MD. He has broad pharmaceutical industry experience in scientific affairs, business development and licensing, and international pharmaceutical operations and has twice served as an independent director on the boards of clinical-stage biotechnology companies. John has also advised the academic sector on translational medicine applications and pharmaceutical clients on partnering strategies, licensing deals, patent disputes, and market research to create credible value propositions for health sciences products. During his time at Veradigm, John has fostered and sustained understanding of the potential utility of healthcare technology to life sciences stakeholders and the patients they serve.